Skip to main content
Nafpenzal dc, suspensão intramamária para bovinos e ovinos
  • Nafcillin
  • PROCAINE BENZYLPENICILLIN
  • Dihidrostreptomicīns
  • Valid

Product identification

Medicine name:
Nafpenzal dc, suspensão intramamária para bovinos e ovinos
Active substance and strength:
  • Nafcillin
    100.00
    milligram(s)
    /
    1.00
    Syringe
  • PROCAINE BENZYLPENICILLIN
    300.00
    milligram(s)
    /
    1.00
    Syringe
  • Dihidrostreptomicīns
    100.00
    milligram(s)
    /
    1.00
    Syringe
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51RC23
Authorisation number:
  • 1248/01/19NFVPT
Product identification number:
  • 2f4fc526-6872-4727-bda9-e77d14fd0174
Permanent identification number:
  • 600000097923

Product details

Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle (dairy cow at drying-off)
      • Meat and offal
        16
        day
      • Milk
        42
        day
    • Sheep (dry ewe)
      • Meat and offal
        28
        day
      • Milk
        3
        month

Availability

Package description:
Manufacturing sites for batch release:
  • Intervet International B.V.
Source wholesaler:
This information is not available for this product.
Destination wholesaler:
This information is not available for this product.

Authorisation details

Authorisation status:
  • Valid
Authorisation procedure type:
  • Marketing Authorisation
Procedure number:
This information is not available for this product.
Date of authorisation status change:
Authorisation country:
  • Portugal
Responsible authority:
  • DGAV
Marketing authorisation holder:
  • MSD Animal Health Lda.
Marketing authorisation issued:
Reference member state:
This information is not available for this product.
Concerned member states:
This information is not available for this product.
Reference product identifier:
This information is not available for this product.
Source product identifier:
This information is not available for this product.

Additional information

To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet

Documents

First published:
Last updated:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."